Clinical Trial Update: Efficacy and Safety of CR6261 in an H1N1 Influenza Healthy Volunteer Human Challenge Model [Phase 2]

View source ↗

Summary

Phase 2 trial update on CR6261 for efficacy and safety in an H1N1 influenza healthy volunteer challenge model; results completed with posted results in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• H1n1 Influenza

Drugs mentioned

• CR6261 (CR6261)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: H1N1 Influenza Healthy Volunteers | Phase 2 | Status: COMPLETED | Results posted: 2020-02-17